Impact of drug-eluting stent type on periprocedural myocardial necrosis

EuroIntervention

Volumn 7, Issue 1, 2011, Pages 136-142

  Wakabayashi, Kohei ^a   Delhaye, Cedric ^a   Mahmoudi, Michael ^a   Belle, Loic ^a   Ben Dor, Itsik ^a   Gaglia Jr , Michael A ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Creatine phosphokinase MB; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

CREATINE KINASE MB; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS ELUTING STENT; ZOTAROLIMUS ELUTING STENT; BLOOD; HEART MUSCLE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; PATHOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; CREATINE KINASE, MB FORM; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; NECROSIS; SIROLIMUS;

EID: 80051729107     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I1A22     Document Type: Article

References (18)

1. Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, Topol EJ. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 1999;33:88-96. (Pubitemid 29064078)
2. Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implications of creatine kinase elevation following elective coronary interventions. JAMA 1997;227: 461-466. (Pubitemid 27074329)
3. Saucedo JF, Mehran R, Dangas G, Hong MK, Lansky A, Kent KM, Satler LF, Pichard AD, Stone GW, Leon MB. Long-term clinical events following creatine-kinase myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-1141. (Pubitemid 30206886)
4. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation1996;94:1528-1536. (Pubitemid 26320254)
5. Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1406-1411. (Pubitemid 37267281)
6. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions. Circulation2000;101:604-610.
7. Cai Q, Skelding KA, Armstrong AT Jr, Desai D, Wood GC, Blankenship JC. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention. Am J Cardiol 2007;99:616-620.
8. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation2009;119:680-686.
9. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE; ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 2006;48:2440-2447. (Pubitemid 44881222)
10. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, Simoons ML. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002;105: 554-556. (Pubitemid 34123427)
11. Yen MH, Topol EJ. Atheromatous showers, periprocedural myocardial infarction, and fatality. Am Heart J 2003;145:933-935. (Pubitemid 36688239)
12. Carlino M, De Gregorio J, Di Mario C, Anzuini A, Airoldi F, Albiero R, Briguori C, Dharmadhikari A, Sheiban I, Colombo A. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999;99:3221-3223. (Pubitemid 29293429)
13. Qian J, Maehara A, Mintz GS, Margolis MP, Lerman A, Rogers J, Banai S, Kazziha S, Castellanos C, Dani L, Fahy M, Stone GW, Leon MB. Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). Am J Cardiol 2009;103:1210-1214.
14. Ormiston JA, Mahmud E, Turco MA, Popma JJ, Weissman N, Cannon LA, Mann T, Lucca MJ, Lim ST, Hall JJ, McClean D, Dobies D, Mandinov L, Baim DS. Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study. JACC Cardiovasc Interv 2008;1:150-160. (Pubitemid 351506555)
15. Okabe T, Lindsay J, Torguson R, Steinberg DH, Roy P, Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Pichard AD, Waksman R. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv 2008;72:799-803.
16. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE; Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290. (Pubitemid 34260417)
17. Hong YJ, Pichard AD, Mintz GS, Kim SW, Lee SY, Kim SY, Ahn Y, Jeong MH, Satler LF, Kent KM, Suddath WO, Weissman NJ, Kang JC, Waksman R. Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Am J Cardiol 2010;105:179-185.
18. Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009;54: 2157-2163.